Our Clients

Skylark has successfully developed and led a bespoke range of Commercial Excellence projects for FTSE 100, global privately owned and medium sized pharmaceutical companies.

We fully respect commercial confidentiality and therefore do not publish client lists, however we do have agreement to share examples of clients’ needs that have been successfully met through their partnership with Skylark:

A European Local Operating Company was falling short of achieving near term growth objectives.

How could they identify and unblock the critical barriers to success? What was the right turnaround plan to transform the effectiveness of an underperforming commercial team?

A rapidly growing Emerging Market needed to accelerate the development of their commercial excellence capability.

How to be competitive in a fast growing environment and capitalise on a 65% increase in sales force size to 1000 Medical Representatives?

Sales Force size was reduced by 20% in a European Local Operating Company.

How to develop and implement a new commercial excellence strategy with a move from a share of voice to a share of value model? What was the best way to design and develop a transition plan to enable them to move from old to new world?

A successful Emerging Market local operating company had made many changes but needed to continue to achieve competitive advantage in a highly dynamic market place.

What was the diagnosis of their current level of commercial excellence and what were the recommendations for sustainable success over the next three years?

Marketing capability was challenged within a large Emerging Market.

How to diagnose, design and develop a Marketing Excellence Programme that would deliver competitive advantage within one year?

A new Commercial Head was moving to an above country role responsible for leading Commercial Excellence across Emerging Markets and Asia Pacific.

How to accelerate the start up and impact of this individual in a key leadership position?